// App-Quantinova.ai

: Combinatorial Genetics Uncovers Novel Targets for the Treatment of Npm1/Cohesin Mutated AML

Researchers

Presenter

  • Alison E Meyer

Principal Investigators

  • Cary Stelloh

  • Joseph B Fisher

  • Kirthi Pulakanti

  • George S. Vassiliou

  • Aaron D Viny

  • Ross L. Levine

  • Sridhar Rao

Medical Centers

  • Blood Research Institute, BloodCenter of Wisconsin, Milwaukee, WI

  • Blood Research Institute, BloodCenter of Wisconsin, Milwaukee, WI

  • Department of Natural Sciences, Concordia University Wisconsin, Mequon, WI

  • Department of Haematology, Hills Road, Wellcome Trust-MRC Cambridge Stem Cell Institute, Cambridge, United Kingdom

  • Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY

  • Center for Health Policy and Outcomes, Memorial Sloan Kettering Cancer Center, New York, NY

  • Blood Research Institute, BloodCenter of Wisconsin, Milwaukee, WI

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute myelocytic leukemia

  • Solid malignancies

Biomarkers

  • Nucleophosmin 1

Drug/Treatment

  • Methadone hydrochloride

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved